Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), continues to pose a
major public health problem and is the leading cause of mortality in people infected with …

Two and a half years into the unprecedented pandemic outbreak of novel Coronavirus
disease 2019 (COVID-19), health services worldwide remain on alert despite rapid …

In this review, 72 compounds isolated from marine‐derived Penicillium fungi and their
antimicrobial activities are reviewed from 2020 to 2023. According to their structures, these …

Tuberculosis (TB) is a bacterial disease that remains a global health threat due to the
millions of deaths attributed to it each year. The emergence of drug resistance has …

An estimated 19 million people are infected with rifampicin-resistant/multidrug-resistant
strains of tuberculosis worldwide. There is little done to prevent these individuals from …

Tuberculosis (TB), caused by respiratory Mycobacterium tuberculosis (Mtb) infection,
remains a major global threat to human health. According to the World Health Organization …

Background: Rifampicin resistant tuberculosis is a serious problem faced by tuberculosis
control in China, and rapid detection of rifampicin resistance is urgently needed. Objectives …

This comprehensive review delves into the intricate landscape of multidrug-resistant
tuberculosis (MDR-TB) treatment within the programmatic management of drug-resistant …

结核病是全球第十三大死亡原因之一, 2021 年全球结核病发病率有所上升, 全球耐药结核病负担
也有所增加. 目前耐药结核病的治疗方法大多为化疗, 也有免疫治疗, 介入治疗, 外科疗法 …

The research in this thesis revealed that, based on big data analysis, there is still much room
for improvement in tuberculosis (TB) treatment. It emphasized the need to consider …